Table 1.
SLC family | Gene | Alias | Substrates | Cell type | Findings | Reference |
---|---|---|---|---|---|---|
SLC2 | SLC2A1 SLC2A2 |
GLUT1 GLUT2 |
DHA, glucose, galactose, mannose, glucosamine |
Chondrocytes | DHA transported via GLUT1 regulated by hypoxia | (69) |
SLC5 | SLC5A12 | SMCT2 | Short chain fatty acids | CD4+ T cells | Lactate regulates T-cell migration and regulates metabolism and inflammation | (70), (47) |
SLC7 | SLC7A5 | LAT1 | Large neutral AA | Monocytes Macrophages | Glycolytic reprogramming through SLC7A5 in immune response | (71) |
SLC7 | SLC7A11 | XC- | Cysteine, glutamate | Endothelial cells | Sulfasalazine inhibits fibroblast growth-factor induced chemotaxis of endothelial cells | (72) |
SLC16 | SLC16A1 | MCT1 | Lactate, pyruvate, ketone bodies |
T cells | Lactate regulates T-cell migration and regulates metabolism and inflammation | (70) |
SLC29 | SLC29A1 | ENT1 | Nucleoside | T cells in animal model | Decitabine therapy results in long-term remission of RA | (72) |
SLC29 | SLC29A1 SLC29A2 |
ENT1 ENT2 |
Nucleoside | Mixed synovial cells | Dipyridamole is an ENT inhibitor. It did not affect cytokine release in RA and OA cells | (73) |
SLC38 | SLC38A1 SLC38A2 SLC38A3 |
SNAT1 SNAT2 SNAT4 |
Gln, Ala, Asp, Cys, His, Ser |
Monocytes Neutrophils AIA |
Glutamine uptake is regulated by SNAT and attenuated AIA | (74) |
SLC39 | SLC39A8 | ZIP8 | Zinc | Macrophages | Zinc regulated IL-1β | (75) |
SLC63 | SLC63A2 | SPNS2 | Sphingolipids | CIA model | SPNS2 deletion improved arthritis | (76) |
CIA, collagen induced arthritis; AIA, antigen induced arthritis, AA, amino acids; GLUT, glucose transporter; SMCT2, sodium-coupled monocarboxylate transporters; LAT1, L-type amino acid transporter; MCT1, monocarboxylate transporter 1; ENT, Equilibrative nucleoside transporter; SNAT, Sodium-Coupled Neutral Amino Acid Transporter; ZIP, Zrt- and Irt-like proteins; SPNS2, Sphingolipid Transporter 2; DHA, Dehydroascorbate